Cargando…

High-soluble CGA levels are associated with poor survival in bladder cancer

Recently, a neuroendocrine-like molecular subtype has been discovered in muscle-invasive urothelial bladder cancer (BC). Chromogranin A (CGA) is a widely used tissue and serum marker in neuroendocrine tumors. Our aim was to evaluate serum CGA (sCGA) concentrations and their associations with clinica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szarvas, T, Jardin-Watelet, B, Bourgoin, N, Hoffmann, M J, Nyirády, P, Oláh, C, Széll, T, Csizmarik, A, Hadaschik, B, Reis, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510714/ https://www.ncbi.nlm.nih.gov/pubmed/30999279 http://dx.doi.org/10.1530/EC-19-0068

Ejemplares similares

Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients
por: Olah, Csilla, et al.
Publicado: (2020)

MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer Patients
por: Szarvas, Tibor, et al.
Publicado: (2020)

Elevated Pre-Treatment Serum MMP-7 Levels Are Associated with the Presence of Metastasis and Poor Survival in Upper Tract Urothelial Carcinoma
por: Kovács, Petra Terézia, et al.
Publicado: (2022)

High Serum PD-L1 Levels Are Associated with Poor Survival in Urothelial Cancer Patients Treated with Chemotherapy and Immune Checkpoint Inhibitor Therapy
por: Krafft, Ulrich, et al.
Publicado: (2021)

Correction to: COVID-19 research: promising tracks leading to uro-oncology
por: Fazekas, Tamás, et al.
Publicado: (2020)

COVID-19 research: promising tracks leading to uro-oncology
por: Tamás, Fazekas, et al.
Publicado: (2020)

Pre-treatment soluble PD-L1 as a predictor of overall survival for immune checkpoint inhibitor therapy: a systematic review and meta-analysis
por: Széles, Ádám, et al.
Publicado: (2022)

High Pretreatment Serum PD-L1 Levels Are Associated with Muscle Invasion and Shorter Survival in Upper Tract Urothelial Carcinoma
por: Széles, Ádám, et al.
Publicado: (2022)

Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancer
por: Olah, Csilla, et al.
Publicado: (2022)

Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data
por: Reis, Henning, et al.
Publicado: (2018)

Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomas
por: Varadi, Melinda, et al.
Publicado: (2023)

Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?
por: Szarvas, Tibor, et al.
Publicado: (2019)

Serum and tissue syndecan-1 levels in renal cell carcinoma
por: Niedworok, Christian, et al.
Publicado: (2020)

Complete Genome Sequence of Rhodopseudomonas palustris CGA0092 and Corrections to the R. palustris CGA009 Genome Sequence
por: Mazny, Brittany E., et al.
Publicado: (2023)

Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder Cancer
por: Wessolly, Michael, et al.
Publicado: (2022)

Therapeutic sensitivity to standard treatments in BRCA positive metastatic castration-resistant prostate cancer patients—a systematic review and meta-analysis
por: Fazekas, Tamás, et al.
Publicado: (2022)

Comprehensive Analysis of the Prognostic Value of Circulating MMP-7 Levels in Urothelial Carcinoma: A Combined Cohort Analysis, Systematic Review, and Meta-Analysis
por: Kubik, András, et al.
Publicado: (2023)

Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer
por: Csizmarik, Anita, et al.
Publicado: (2022)

cgaTOH: Extended Approach for Identifying Tracts of Homozygosity
por: Zhang, Li, et al.
Publicado: (2013)

Efficacy of immune checkpoint inhibitor therapy for advanced urothelial carcinoma in real-life clinical practice: results of a multicentric, retrospective study
por: Váradi, Melinda, et al.
Publicado: (2023)

Prevalence of APC and PTEN Alterations in Urachal Cancer
por: Nagy, Nikolett, et al.
Publicado: (2020)

Identification of factors that promote biogenesis of tRNA(CGA)(Ser)
por: Xu, Fu, et al.
Publicado: (2018)

Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer
por: Keresztes, Dávid, et al.
Publicado: (2021)

Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor: a retrospective analysis of 143 patients
por: Rehme, Christian, et al.
Publicado: (2021)

Why are upper tract urothelial carcinoma two different diseases?
por: Szarvas, Tibor, et al.
Publicado: (2016)

Molecular modelling and docking of Mus musculus HMGB1 inflammatory protein with CGA
por: Tripathi, Alok, et al.
Publicado: (2019)

Chromogranin A (CgA) as Poor Prognostic Factor in Patients with Small Cell Carcinoma of the Cervix: Results of a Retrospective Study of 293 Patients
por: Liao, Ling-Min, et al.
Publicado: (2012)

Insights into arsenic multi-operons expression and resistance mechanisms in Rhodopseudomonas palustris CGA009
por: Zhao, Chungui, et al.
Publicado: (2015)

Molecular Design, Structural Analysis and Antifungal Activity of Derivatives of Peptide CGA-N46
por: Li, Rui-Fang, et al.
Publicado: (2016)

A Methodology for the Hybridization Based in Active Components: The Case of cGA and Scatter Search
por: Villagra, Andrea, et al.
Publicado: (2016)

Expression of chromogranin A-derived antifungal peptide CGA-N12 in Pichia pastoris
por: Li, Xiaohua, et al.
Publicado: (2020)

Salivary Chromogranin A (CgA) Response to the Noradrenaline Transporter Blocker Atomoxetine in Dogs
por: Kooriyama, Takanori, et al.
Publicado: (2021)

Identification of Factors Affecting the Increased Percentage of CGA Recommendations among Patients on Geriatric Ward
por: Gołębiowska, Justyna, et al.
Publicado: (2023)

CGA-MGAN: Metric GAN Based on Convolution-Augmented Gated Attention for Speech Enhancement
por: Chen, Haozhe, et al.
Publicado: (2023)

CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
por: Li, Yuan, et al.
Publicado: (2016)

Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer: a comparison of two sequencing methods and gene sets using FFPE specimens
por: Koll, Florestan J., et al.
Publicado: (2023)

5′-(CGA)(n) sequence-assisted pH-controlled assembly of supramolecular DNA nanostructure
por: Yan, Yuting, et al.
Publicado: (2018)

The chromogranin A-derived antifungal peptide CGA-N9 induces apoptosis in Candida tropicalis
por: Li, Ruifang, et al.
Publicado: (2019)

Promoting Early Assessment of Frailty in the New Normal: An Updated eFI-CGA Software Tool
por: Sepehri, Katayoun, et al.
Publicado: (2021)

Heterologous phasin expression in Rhodopseudomonas palustris CGA009 for bioplastic production from lignocellulosic biomass
por: Brown, Brandi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_amnvsb0bihcnel4mnvp6av2e6d